Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000401518

Medchemexpress LLC Glesatinib hydrochloride | 2319837-80-2 | 98.01% | 656.17 | 100 MG
SDP

Catalog No. 5000401518
Encompass_Preferred

Glesatinib hydrochloride (MGCD265 hydrochloride) is an orally active, potent MET/SMO dual inhibitor. This tyrosine kinase inhibitor also antagonizes P-glycoprotein (P-gp) mediated multidrug resistance (MDR) in non-small cell lung cancer (NSCLC). It is intended for research use only and not for patient use.

  • Orally active
  • Potent MET/SMO dual inhibitor
  • Tyrosine kinase inhibitor
  • Antagonizes P-glycoprotein (P-gp) mediated multidrug resistance (MDR) in non-small cell lung cancer (NSCLC)

Catalog No. 50-004-01518 Supplier Medchemexpress LLC Supplier No. HY19642A100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Glesatinib hydrochloride (MGCD265 hydrochloride) is an orally active, potent MET/SMO dual inhibitor. This tyrosine kinase inhibitor also antagonizes P-glycoprotein (P-gp) mediated multidrug resistance (MDR) in non-small cell lung cancer (NSCLC). It is intended for research use only and not for patient use.

  • Orally active
  • Potent MET/SMO dual inhibitor
  • Tyrosine kinase inhibitor
  • Antagonizes P-glycoprotein (P-gp) mediated multidrug resistance (MDR) in non-small cell lung cancer (NSCLC)

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.